VG Life Sciences Inc. (VGLS)

[jurisper]

Double/nothing it is!

The people you cite are helping VG with VG1177. Some of the consulting contracts are in the attachments & my reading of them is that things are still at a very early stage. This is confirmed by the commentary on p7:

We began animal toxicity studies [on VG1177 ] in November 2013[..] These toxicity studies are the prerequisite step before beginning a Phase I clinical trial. We expect these safety results in late 2014. We have engaged an additional team of industry consultants to guide us through this pivotal, pre-FDA planning stage with a specific focus on drug formulation, on-site inspections, clinical creation and other aspects of clinical planning. This group of advisors includes [those people you mentioned] ...

So at the very best they may have started a Phase I by the end of the year - surely not enough data to get anybody interested enough to do a meaningful deal on that timeframe. The consultants have been engaged at this stage to help put together the IND submission - a long way to go ...